Detection of clonal evolution in hematopoietic malignancies by combining comparative genomic hybridization and single nucleotide polymorphism arrays

Clinical Chemistry

Volumn 60, Issue 12, 2014, Pages 1558-1568

  Hartmann, Luise ^a   Stephenson, Christine F ^a   Verkamp, Stephanie R ^a   Johnson, Krystal R ^a   Burnworth, Bettina ^a   Hammock, Kelle ^a   Brodersen, Lisa Eidenschink ^a   De Baca, Monica E ^a   Wells, Denise A ^a   Loken, Michael R ^a   Zehentner, Barbara K ^a  

^a HEMATOLOGICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLONAL EVOLUTION; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC HETEROGENEITY; HEMATOLOGIC MALIGNANCY; HETEROZYGOSITY LOSS; HUMAN; INTERMETHOD COMPARISON; MICROARRAY ANALYSIS; MYELODYSPLASTIC SYNDROME; PLASMACYTOMA; SINGLE NUCLEOTIDE POLYMORPHISM; UNIPARENTAL DISOMY; DNA MICROARRAY; GENETICS; HEMATOLOGIC DISEASE; PATHOLOGY;

CLONAL EVOLUTION; COMPARATIVE GENOMIC HYBRIDIZATION; HEMATOLOGIC NEOPLASMS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84924455179     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2014.227785     Document Type: Article

References (37)

1. Maciejewski JP, Tiu RV, O'Keefe C. Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies. Br J Haematol 2009;146:479-88.
2. Speicher MR, Carter NP. The new cytogenetics: Blurring the boundaries with molecular biology.Nat Rev Genet 2005;6:782-92.
3. Gutiérrez NC, García JL, Hernández JM, Lumbreras E, Castellanos M, Rasillo A, Mateo G, Pérez S, Orfao A, San Miguel JF. Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma. Blood 2004;104:2661-6.
4. Bullinger L, Fröhling S. Array-based cytogenetic approaches in acute myeloid leukemia: clinical impact and biological insights. Semin Oncol 2012;39: 37-46.
5. Kolquist KA, Schultz RA, Furrow A, Brown TC, Han JY, Campbell LJ, et al. Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes. Cancer Genet 2011; 204:603-28.
6. Edelmann J, Holzmann K, Miller F, Winkler D, Bühler A, Zenz T, et al. High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. Blood 2012; 120:4783-94.
7. Zehentner BK, Hartmann L, Johnson KR, Stephenson CF, Chapman DB, de Baca ME, et al. Arraybased karyotyping in plasma cell neoplasia after plasma cell enrichment increases detection of genomic aberrations. Am J Clin Pathol 2012;138: 579-89.
8. Parker H, Rose-Zerilli MJ, Parker A, Chaplin T, Wade R, Gardiner A, et al. 13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia. Leukemia 2011;25:489-97.
9. Gijsbers AC, Ruivenkamp CA. Molecular karyotyping: From microscope to SNP arrays. Horm Res Paediatr 2011;76:208-13.
10. Sato-Otsubo A, Sanada M, Ogawa S. Singlenucleotide polymorphism array karyotyping in clinical practice: Where, when, and howC Semin Oncol 2012;39:13-25.
11. Robinson WP. Mechanisms leading to uniparental disomy and their clinical consequences. Bioessays 2000;22:452-9.
12. Tuna M, Knuutila S, Mills GB. Uniparental disomy in cancer. Trends Mol Med 2009;15:120-8.
13. Mohamedali A, Gäken J, Twine NA, Ingram W, Westwood N, Lea NC, et al. Prevalence and prognostic significance of allelic imbalance by singlenucleotide polymorphism analysis in low-risk myelodysplastic syndromes. Blood 2007;110: 3365-73.
14. Tan DS, Lambros MB, Natrajan R, Reis-Filho JS. Getting it right: designing microarray (and not 'microawry') comparative genomic hybridization studies for cancer research. Lab Invest 2007;87: 737-54.
15. Huh J, Mun YC, Seong CM, Chung WS. Single nucleotide polymorphism array-based karyotyping shows sequential genomic changes from monosomy to copy-neutral loss of heterozygosity of chromosome 7 and 20q deletion within a balanced translocation t(14;20) in AML. Cancer Genet 2011;204:682-6.
16. Stölzel F, Hackmann K, Kuithan F, Mohr B, Füssel M, Oelschlägel U, et al. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation. Transplantation 2012;93:744-9.
17. Jasmine F, Rahaman R, Dodsworth C, Roy S, Paul R, Raza M, et al. A genome-wide study of cytogenetic changes in colorectal cancer using SNP microarrays: opportunities for future personalized treatment. PLoS One 2012;7:e31968.
18. Repnikova EA, Astbury C, Reshmi SC, Ramsey SN, Atkin JF, Thrush DL, et al. Microarray comparative genomic hybridization and cytogenetic characterization of tissue-specific mosaicism in three patients. Am J Med Genet A 2012;158A:1924-33.
19. Zhang L, Znoyko I, Costa LJ, Conlin LK, Daber RD, Self SE, Wolff DJ. Clonal diversity analysis using SNP microarray: A new prognostic tool for chronic lymphocytic leukemia. Cancer Genet 2011;204: 654-65.
20. Rodríguez-Santiago B, Malats N, Rothman N, Armengol L, Garcia-Closas M, Kogevinas M, et al. Mosaic uniparental disomies and aneuploidies as large structural variants of the human genome. Am J Hum Genet 2010;87:129-38.
21. Valli R, Maserati E, Marletta C, Pressato B, Lo Curto F, Pasquali F. Evaluating chromosomal mosaicism by array comparative genomic hybridization in hematological malignancies: The proposal of a formula. Cancer Genet 2011;204:216-8.
22. Liu F, Yoshida N, Suguro M, Kato H, Karube K, Arita K, et al. Clonal heterogeneity of mantle cell lymphoma revealed by array comparative genomic hybridization. Eur J Haematol 2013; 90:51-8.
23. Yoshida N, Umino A, Liu F, Arita K, Karube K, Tsuzuki S, et al. Identification of multiple subclones in peripheral T-cell lymphoma, not otherwise specified with genomic aberrations. Cancer Med 2012;1:289-94.
24. Umino A, Nakagawa M, Utsunomiya A, Tsukasaki K, Taira N, Katayama N, Seto M. Clonal evolution of adult T-cell leukemia/lymphoma takes place in the lymph nodes. Blood 2011;117:5473-8.
25. Janssens A, Van Roy N, Poppe B, Noens L, Philippé J, Speleman F, Offner F. High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature. Eur J Haematol 2012;89:72-80.
26. Gerlinger M, Swanton C. How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine. Br J Cancer 2010; 103:1139-43.
27. Wang H, Wang XQ, Xu XP, Lin GW. Cytogenetic evolution correlates with poor prognosis in myelodysplastic syndrome. Cancer Genet Cytogenet 2010;196:159-66.
28. Vermeesch JR, Brady PD, Sanlaville D, Kok K, Hastings RJ. Genome-wide arrays: quality criteria and platforms to be used in routine diagnostics. Hum Mutat 2012;33:906-15.
29. Costa P, De Witte A, Ghosh J. Detecting copyneutral LOH in cancer using Agilent SurePrint G3 Cancer CGH-SNP Microarrays: Application note. http://www.chem.agilent.com/library/applications/5990-9183en-lo.pdf(Accessed August 2013).
30. Grimwade D, Mrózek K. Diagnostic and prognostic value of cytogenetics in acute myeloid leukemia. Hematol Oncol Clin North Am 2011;25: 1135-61.
31. Döhner H, Estey EH, Amadori S, Appelbaum FR, Bü chner T, Burnett AK, et al. Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010;115:453-74.
32. Kim Y, Jang J, Hyun SY, Hwang D, Kim SJ, Kim JS, et al. Karyotypic change between diagnosis and relapse as a predictor of salvage therapy outcome in AML patients. Blood Res 2013;48:24-30.
33. Kern W, Haferlach T, Schnittger S, Ludwig WD, Hiddemann W, Schoch C. Karyotype instability between diagnosis and relapse in 117 patients with acute myeloid leukemia: implications for resistance against therapy. Leukemia 2002;16: 2084-91.
34. Carrasco DR, Tonon G, Huang Y, Zhang Y, Sinha R, Feng B, et al. High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. Cancer Cell 2006;9: 313-25.
35. Greslikova H, Zaoralova R, Filkova H, Nemec P, Oltova A, Kupska R, et al. Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation. Neoplasma 2010;57:111-7.
36. Hartmann L, Biggerstaff JS, Chapman DB, Scott JM, Johnson KR, Ghirardelli KM, et al. Detection of genomic abnormalities in multiple myeloma: The application of FISH analysis in combination with various plasma cell enrichment techniques. Am J Clin Pathol 2011;136:712-20.
37. American College of Medical Genetics. Standards and Guidelines for Clinical Genetics Laboratories. 2009 ed., revised 01/2010. Section E, Clinical cytogenetics. https://www.acmg.net/StaticContent/SGs/Section-E-2011.pdf (Accessed October 2014).